CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13620570

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent following administration for a time period ranging from about 2 to about 24 hours or longer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALKERMES PHARMA IRELAND LIMITEDDUBLIN 4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clancy, Maurice Joseph Anthony Dublin, IE 20 584
Codd, Janet Elizabeth Athlone, IE 14 518
Cumming, Kenneth Iain Essex, GB 17 910
Devane, John G Athlone, IE 27 1757
Hontz, Robert Newton Square, US 8 277
Jain, Rajeev A Framingham, US 24 902
Liversidge, Gary G Charlestown, US 44 3454
Swanson, Jon North Wales, US 15 491

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation